Journal
CANADIAN MEDICAL ASSOCIATION JOURNAL
Volume 172, Issue 11, Pages 1461-1471Publisher
CMA-CANADIAN MEDICAL ASSOC
DOI: 10.1503/cmaj.1040847
Keywords
-
Categories
Ask authors/readers for more resources
WITH THE INCREASING USE OF CONTRAST MEDIA in diagnostic and interventional procedures, nephropathy induced by contrast media has become the third leading cause of hospital- acquired acute renal failure. It is also associated with a significant risk of morbidity and death. The current understanding of the pathogenesis indicates that contrast- medium nephropathy is caused by a combination of renal ischemia and direct toxic effects on renal tubular cells. Patients with pre- existing renal insufficiency, diabetes mellitus and congestive heart failure are at highest risk. Risk factors also include the type and amount of contrast medium administered. Therapeutic prevention strategies are being extensively investigated, but there is still no definitive answer. In this article, we review the current evidence on the causes, pathogenesis and clinical course of contrast- medium nephropathy as well as therapeutic approaches to its prevention evaluated in clinical trials.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available